Porcine xenograft biosynthetic wound dressings for the management of postoperative Mohs wounds

David W. Raimer, Ashley Group, Matthew S. Petitt, Neda Nosrati, Mika L. Yamazaki, Nathan A. Davis, Brent Kelly, Bernard Gibson, Richard D. Montilla, Richard Wagner

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Cadaveric allografts and a large variety of other biologic dressings have been reported as being useful for the postoperative management of Mohs micrographic surgery (MMS) wounds. Although the use of porcine xenografts for the immediate postoperative management of these wounds is known, their use has not been detailed in the dermatology literature. A case series of 15 consecutive Mohs micrographic surgery patients (mean age = 74.9 years, range = 49 to 89 years) with wounds initially managed with porcine xenografts is described. Porcine xenografts were useful in a variety of clinical settings following MMS. These included: 1. wound management when tumor margins were indeterminate pending additional dermatopathology studies and 2. wound management when there are issues such as through and through nasal defects involving the mucosa, large wound depth, exposed cartilage and or bone, or patient medical comorbidities that delay or prevent plans for immediate wound reconstruction. Future controlled studies of biologic dressings are needed to determine which options are best for micrographic surgery wounds. Comparisons should also include the traditional option of second intention healing without biologic dressings.

Original languageEnglish (US)
Pages (from-to)1
Number of pages1
JournalDermatology Online Journal
Volume17
Issue number9
StatePublished - 2011

Fingerprint

Bandages
Heterografts
Swine
Biological Dressings
Wounds and Injuries
Mohs Surgery
Dermatology
Nose
Cartilage
Allografts
Comorbidity
Mucous Membrane
Bone and Bones
Neoplasms

ASJC Scopus subject areas

  • Dermatology

Cite this

Raimer, D. W., Group, A., Petitt, M. S., Nosrati, N., Yamazaki, M. L., Davis, N. A., ... Wagner, R. (2011). Porcine xenograft biosynthetic wound dressings for the management of postoperative Mohs wounds. Dermatology Online Journal, 17(9), 1.

Porcine xenograft biosynthetic wound dressings for the management of postoperative Mohs wounds. / Raimer, David W.; Group, Ashley; Petitt, Matthew S.; Nosrati, Neda; Yamazaki, Mika L.; Davis, Nathan A.; Kelly, Brent; Gibson, Bernard; Montilla, Richard D.; Wagner, Richard.

In: Dermatology Online Journal, Vol. 17, No. 9, 2011, p. 1.

Research output: Contribution to journalArticle

Raimer, DW, Group, A, Petitt, MS, Nosrati, N, Yamazaki, ML, Davis, NA, Kelly, B, Gibson, B, Montilla, RD & Wagner, R 2011, 'Porcine xenograft biosynthetic wound dressings for the management of postoperative Mohs wounds', Dermatology Online Journal, vol. 17, no. 9, pp. 1.
Raimer DW, Group A, Petitt MS, Nosrati N, Yamazaki ML, Davis NA et al. Porcine xenograft biosynthetic wound dressings for the management of postoperative Mohs wounds. Dermatology Online Journal. 2011;17(9):1.
Raimer, David W. ; Group, Ashley ; Petitt, Matthew S. ; Nosrati, Neda ; Yamazaki, Mika L. ; Davis, Nathan A. ; Kelly, Brent ; Gibson, Bernard ; Montilla, Richard D. ; Wagner, Richard. / Porcine xenograft biosynthetic wound dressings for the management of postoperative Mohs wounds. In: Dermatology Online Journal. 2011 ; Vol. 17, No. 9. pp. 1.
@article{3b3375fbbe09453da37acef8f0523fa1,
title = "Porcine xenograft biosynthetic wound dressings for the management of postoperative Mohs wounds",
abstract = "Cadaveric allografts and a large variety of other biologic dressings have been reported as being useful for the postoperative management of Mohs micrographic surgery (MMS) wounds. Although the use of porcine xenografts for the immediate postoperative management of these wounds is known, their use has not been detailed in the dermatology literature. A case series of 15 consecutive Mohs micrographic surgery patients (mean age = 74.9 years, range = 49 to 89 years) with wounds initially managed with porcine xenografts is described. Porcine xenografts were useful in a variety of clinical settings following MMS. These included: 1. wound management when tumor margins were indeterminate pending additional dermatopathology studies and 2. wound management when there are issues such as through and through nasal defects involving the mucosa, large wound depth, exposed cartilage and or bone, or patient medical comorbidities that delay or prevent plans for immediate wound reconstruction. Future controlled studies of biologic dressings are needed to determine which options are best for micrographic surgery wounds. Comparisons should also include the traditional option of second intention healing without biologic dressings.",
author = "Raimer, {David W.} and Ashley Group and Petitt, {Matthew S.} and Neda Nosrati and Yamazaki, {Mika L.} and Davis, {Nathan A.} and Brent Kelly and Bernard Gibson and Montilla, {Richard D.} and Richard Wagner",
year = "2011",
language = "English (US)",
volume = "17",
pages = "1",
journal = "Dermatology Online Journal",
issn = "1087-2108",
publisher = "Department of Dermatology UC Davis",
number = "9",

}

TY - JOUR

T1 - Porcine xenograft biosynthetic wound dressings for the management of postoperative Mohs wounds

AU - Raimer, David W.

AU - Group, Ashley

AU - Petitt, Matthew S.

AU - Nosrati, Neda

AU - Yamazaki, Mika L.

AU - Davis, Nathan A.

AU - Kelly, Brent

AU - Gibson, Bernard

AU - Montilla, Richard D.

AU - Wagner, Richard

PY - 2011

Y1 - 2011

N2 - Cadaveric allografts and a large variety of other biologic dressings have been reported as being useful for the postoperative management of Mohs micrographic surgery (MMS) wounds. Although the use of porcine xenografts for the immediate postoperative management of these wounds is known, their use has not been detailed in the dermatology literature. A case series of 15 consecutive Mohs micrographic surgery patients (mean age = 74.9 years, range = 49 to 89 years) with wounds initially managed with porcine xenografts is described. Porcine xenografts were useful in a variety of clinical settings following MMS. These included: 1. wound management when tumor margins were indeterminate pending additional dermatopathology studies and 2. wound management when there are issues such as through and through nasal defects involving the mucosa, large wound depth, exposed cartilage and or bone, or patient medical comorbidities that delay or prevent plans for immediate wound reconstruction. Future controlled studies of biologic dressings are needed to determine which options are best for micrographic surgery wounds. Comparisons should also include the traditional option of second intention healing without biologic dressings.

AB - Cadaveric allografts and a large variety of other biologic dressings have been reported as being useful for the postoperative management of Mohs micrographic surgery (MMS) wounds. Although the use of porcine xenografts for the immediate postoperative management of these wounds is known, their use has not been detailed in the dermatology literature. A case series of 15 consecutive Mohs micrographic surgery patients (mean age = 74.9 years, range = 49 to 89 years) with wounds initially managed with porcine xenografts is described. Porcine xenografts were useful in a variety of clinical settings following MMS. These included: 1. wound management when tumor margins were indeterminate pending additional dermatopathology studies and 2. wound management when there are issues such as through and through nasal defects involving the mucosa, large wound depth, exposed cartilage and or bone, or patient medical comorbidities that delay or prevent plans for immediate wound reconstruction. Future controlled studies of biologic dressings are needed to determine which options are best for micrographic surgery wounds. Comparisons should also include the traditional option of second intention healing without biologic dressings.

UR - http://www.scopus.com/inward/record.url?scp=80053004881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053004881&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 1

JO - Dermatology Online Journal

JF - Dermatology Online Journal

SN - 1087-2108

IS - 9

ER -